ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$8.50
+0.20 (+2.41%)
Analyst Consensus
Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+679.1% upside
Low Target
$44.47
Average Target
$66.22
High Target
$75.30
Current Price
$8.50
Current
$8.50
$8.50
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Scenario Analysis
Bear Case
$44.47
423.2%
Low target
Base Case
$66.22
+679.1%
Avg target
Bull Case
$75.30
+785.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$14.51
-41.4% from high
52-Week Low
$6.97
+22.0% from low
Target vs 52W High
$66.22
+356.4% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.8% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.1% |
| MRK | Buy | 36 | 72% | $159.27 | +5.0% |
| PFE | Hold | 36 | 39% | $33.90 | +21.6% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +187.5% |